17.1 Purpose and Principles
- This policy keeps editorial decisions independent from commercial influence. Advertising, sponsorship, and supplements are allowed only when they are clearly labeled, accurate, and separate from peer-reviewed content. Revenue arrangements never affect acceptance decisions, peer review, or research conclusions.
17.2 Firewalls and Governance
- Editorial firewall: Editors, reviewers, and editorial board members have no role in advertising sales, sponsorship negotiations, or billing.
- Commercial firewall: Sales and marketing teams have no access to confidential editorial content or peer-review files.
- Conflict checks: Any staff member involved in both editorial and commercial activities must declare and manage conflicts; dual roles in the same workflow are prohibited.
17.3 Clear Labeling and Distinction
- Display ads are labeled “Advertisement.”
- Sponsored content (publisher-created or partner-provided) is labeled “Sponsored” or “Paid Content,” includes the sponsor’s name, and is not peer reviewed unless explicitly stated.
- Supplements (sponsored issues/collections) are labeled on the cover, table of contents, and each article landing page with sponsor disclosures and the handling editor’s identity.
- Native ads and advertorials are permitted only with unambiguous labeling and a style that prevents confusion with editorial design.
17.4 Placement and Ad Serving
- Ads never appear within peer-review reports, editorial decisions, or PDF article bodies.
- Ads do not interrupt reading flows of article HTML (e.g., no interstitials that block access to the Version of Record).
- We prohibit ad placements adjacent to content where it would create misleading associations (e.g., disease claims next to clinical trial outcomes) unless a clear disclaimer is present.
17.5 Acceptable vs. Prohibited Advertising
- Acceptable: products and services relevant to research, education, healthcare, or professional practice, provided claims are truthful, evidence-based, and lawful in target jurisdictions.
- Prohibited: Illegal products/services; discriminatory or hateful content; political campaign ads; misleading “miracle cures”; spyware or deceptive software; adult sexual content; tobacco; weapons and explosives; predatory publishing services; deepfake or synthetic identity products; any ad that conflicts with our research-integrity standards.
17.6 Claims, Evidence, and Safety
- Health or performance claims must be substantiated by competent evidence; references may be requested.
- Comparative claims require fair comparisons with current, representative products.
- Ads must comply with local law (e.g., device/pharmaceutical rules, financial promotions). We may geo-restrict or decline ads that do not meet standards.
17.7 Targeting, Privacy, and Data Use
- Targeting uses minimal, privacy-respecting data; we do not sell personal data to advertisers.
- Behavioral targeting (if used) follows our Privacy & Cookies policy, honors consent choices, and excludes sensitive attributes (health status, race, religion, sexual orientation).
- Advertisers do not receive access to user-level browsing of peer-review content; reporting is aggregated and de-identified.
17.8 Third-Party Ad Tech and Measurement
- Ad servers and measurement providers must adhere to data-processing agreements and security standards.
- We vet tags/SDKs for privacy, performance, and accessibility impacts; intrusive or unsecure scripts are rejected.
- Metrics (impressions, clicks) are reported consistently and may be audited.
17.9 Editorial Independence in Sponsored Content
- Sponsors have no editorial control over peer-reviewed articles or acceptance decisions.
- For sponsored features (non-peer-reviewed): we retain final edit rights to ensure accuracy, tone, and compliance; sponsor review is limited to factual checking of sponsor-provided details.
- Any financial relationship relevant to content is disclosed prominently.
17.10 Supplements (Sponsored Issues/Collections)
- Peer review: Articles in supplements undergo the same peer-review and ethics standards as regular content; deviations (if any) are stated on the supplement page.
- Oversight: A senior editor (independent from the sponsor) oversees reviewer selection and decisions; sponsors cannot select reviewers or influence outcomes.
- Disclosures: Each article lists the sponsor, funding source, and sponsor role; data access and analysis independence are stated.
- Indexing: Supplements are indexed as part of the scholarly record with their own DOIs; corrections and retractions follow standard policy.
17.11 Industry-Funded Research and Medical Marketing
- Advertisements from pharma/biotech/medical device firms must comply with applicable advertising laws and avoid misleading therapeutic claims.
- Promotion of off-label uses is prohibited.
- Sponsored educational content must disclose all funding and potential conflicts; faculty/speakers provide COI statements.
17.12 Gifts, Inducements, and Undue Influence
- We do not accept gifts, travel, or hospitality that could reasonably be seen as influencing editorial or advertising decisions.
- Discounts, bundled packages, or partner deals must not create preferential editorial treatment.
17.13 Complaints and Corrections (Commercial Content)
- Readers may report misleading or inappropriate ads via a public contact channel.
- We investigate promptly; remedies may include ad removal, labels correction, or public notes.
- For sponsored content and supplements, factual errors are corrected with transparent notices; severe breaches may lead to withdrawal of the item and notice to relevant authorities.
17.14 Archiving and Transparency
- Sponsored materials and supplements are preserved and labeled permanently.
- A public Commercial Content Register lists current and recent sponsors of supplements and major campaigns, with dates and scopes.
17.15 Accessibility and Technical Standards
- Ads and sponsored content must meet WCAG 2.2 AA where feasible; no flashing content >3 Hz; keyboard operable; alt text for informative images.
- Heavy or intrusive creatives (auto-play audio, large CPU usage) are blocked.
17.16 Changes to This Policy
- Substantive changes are versioned with a last-updated date and communicated to advertisers and readers where appropriate.